chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Mastoiditis, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: On 6-25-2022, I started having body aches, headache, temp up to 102.0, shortness of breath, chest pain and a sore throat. On 6-26 I felt as all my symptoms had increased in severity so I called my lung doctor and he told me to go to the ER. They ordered a CT scan of my chest, X-ray of my chest, and blood work. I was also tested for COVID-19 with positive results. I was given an infusion of bebtelovimab antibodies. My fever went away after 48 hours but I am deaf in my left ear now. My primary care doctor sent me to an audiologist on 7-29 who said the ear deafness is likely not permanent. I also had an MRI of my head on 8-23 and they told me I had mastoiditis of left ear that was possibly due to a virus. I am feeling a lot better although with my hearing loss but I do have occasional headaches and vertigo. I am reporting a breakthrough case of COVID-19.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, Vertigo
Clinical narrative: On 6-25-2022, I started having body aches, headache, temp up to 102.0, shortness of breath, chest pain and a sore throat. On 6-26 I felt as all my symptoms had increased in severity so I called my lung doctor and he told me to go to the ER. They ordered a CT scan of my chest, X-ray of my chest, and blood work. I was also tested for COVID-19 with positive results. I was given an infusion of bebtelovimab antibodies. My fever went away after 48 hours but I am deaf in my left ear now. My primary care doctor sent me to an audiologist on 7-29 who said the ear deafness is likely not permanent. I also had an MRI of my head on 8-23 and they told me I had mastoiditis of left ear that was possibly due to a virus. I am feeling a lot better although with my hearing loss but I do have occasional headaches and vertigo. I am reporting a breakthrough case of COVID-19.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Syringe issue
Clinical narrative: Injected into left deltoid. contents of syringe sprayed onto her arm as I injected it. Likely a faulty syringe. Recommended by CDC to administer dose again.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dyspnoea, Nausea
Clinical narrative: SOB, abdominal pain, nausea
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Decreased appetite, Headache, Loss of personal independence in daily activities, Pyrexia
Clinical narrative: Fever, Chills, Shaking uncontrollably, Loss of appetite, needed assistance going to bathroom, Headache
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Tremor
Clinical narrative: Fever, Chills, Shaking uncontrollably, Loss of appetite, needed assistance going to bathroom, Headache
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema, Injection site mass
Clinical narrative: lump at injection site, red in color..smaller than a dime
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Cough, Diarrhoea, Dysuria
Clinical narrative: chills, diaphoresis, fatigue, congestion, rhinorrhea, sore throat, cough, abdominal pain, diarrhea, dysuria, urinary frequency/urgency
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis, Micturition urgency, Oropharyngeal pain, Pollakiuria
Clinical narrative: chills, diaphoresis, fatigue, congestion, rhinorrhea, sore throat, cough, abdominal pain, diarrhea, dysuria, urinary frequency/urgency
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea
Clinical narrative: chills, diaphoresis, fatigue, congestion, rhinorrhea, sore throat, cough, abdominal pain, diarrhea, dysuria, urinary frequency/urgency
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Asthenia, Biopsy lung, Biopsy lymph gland, Blood creatinine increased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium decreased, Blood sodium decreased, Bronchoscopy abnormal, COVID-19, Cough
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Culture positive, Dyspnoea, Hypoxia, Increased bronchial secretion, Lung consolidation
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mediastinal disorder, Pathology test, Pneumonia staphylococcal, Productive cough
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary mass, SARS-CoV-2 test positive, Staphylococcus test positive, Troponin, White blood cell count increased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD   Admission Date: 8/16/2022 Discharge Date: 8/20/2022  HOSPITAL COURSE: Patient is a 67-year-old male with history of coronary artery disease, stage IV CKD, oropharyngeal dysphagia with known aspiration, pulmonary aspergillosis, carotid artery disease and Barrett's esophagus with history of throat cancer who presented with increased cough, shortness of breath, increased sputum production and generalized weakness.  He called EMS, and was placed on 4 L of oxygen due to hypoxia.  Upon arrival to the emergency department, he was noted to have oxygen saturation of 87% on room air, and was placed on 2 L. Labs showed a sodium of 132, potassium 2.7, creatinine 2.57, troponin 69 and WBC count 10.6.  CT angiogram showed diffuse central lobular nodular densities in bilateral lower lobes and consolidation in the left lower lobe.  He was noted to have lymphoid tissue in the mediastinum and hilum.  He was tested for COVID-19, which returned positive.  He was given IV potassium, 1 L of fluids, IV Zosyn and Decadron in the emergency department.  He was admitted to the hospitalist service for further management.   Upon admission, he was continued on Decadron for this COVID-19.  SLP was consulted, given his known history of dysphagia and aspiration.  The patient has continually stated that he will continue with oral intake understanding risk of aspiration, and continued to feel this way.  SLP did not feel that further evaluation was necessary, given this history.  Due to worsening left lower lobe infiltrate and worsening lymphadenopathy, pulmonology was consulted.  Patient was history of pulmonary Aspergillosis, and has been treated with voriconazole by infectious disease.  Therefore, ID was also consulted.  They recommended continued treatment with IV Zosyn and patient was restarted on voriconazole for chronic pulmonary Aspergillosis.  Pulmonology felt that bronchoscopy should be done, and was completed on 8/18.  Bronchoscopy did note purulent secretions and 5 EBUS-guided needle aspirates were obtained for further evaluation of his lymphadenopathy.  Pathology is pending.  Cultures have returned with Staph aureus (sensitivity pending), and he will be placed on a 5-day course of Doxycycline at discharge.  He remained minimally symptomatic and afebrile from a COVID standpoint, and was able to be weaned to room air.   He was felt stable for discharge on 8/20/22.  He will be discharged on 5 days of Doxycycline for treatment of Staph aureus pneumonia.  He will need outpatient follow-up of lymph node biopsy results, and should have follow-up CMP and voriconazole level checked in 7-10 days, per ID recommendations.  He should follow-up with Pulmonology in 1 month.  He should follow-up with his PCP in 1 week.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Respiratory tract congestion
Clinical narrative: congestion, cough
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Chest X-ray, Dyspnoea, Fatigue
Clinical narrative: My son received his second dose of the Pfizer vaccine for COVID-19 on 2/22/2022. On the morning of 5/13/2022, he woke up with a fever, sore throat, and stuffy nose. He was very fatigued and pretty much slept all day long. He also vomited once that day. On 5/14/2022, he wasn't breathing well. We took him to the ER. He was diagnosed with both COVID-19 and pneumonia and was kept in the hospital for 3 days to receive remdesivir. After 3 days, he was pretty much back to normal and was released to go home. He has been fine ever since, though he did have a mild cold at one point.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Pneumonia
Clinical narrative: My son received his second dose of the Pfizer vaccine for COVID-19 on 2/22/2022. On the morning of 5/13/2022, he woke up with a fever, sore throat, and stuffy nose. He was very fatigued and pretty much slept all day long. He also vomited once that day. On 5/14/2022, he wasn't breathing well. We took him to the ER. He was diagnosed with both COVID-19 and pneumonia and was kept in the hospital for 3 days to receive remdesivir. After 3 days, he was pretty much back to normal and was released to go home. He has been fine ever since, though he did have a mild cold at one point.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: My son received his second dose of the Pfizer vaccine for COVID-19 on 2/22/2022. On the morning of 5/13/2022, he woke up with a fever, sore throat, and stuffy nose. He was very fatigued and pretty much slept all day long. He also vomited once that day. On 5/14/2022, he wasn't breathing well. We took him to the ER. He was diagnosed with both COVID-19 and pneumonia and was kept in the hospital for 3 days to receive remdesivir. After 3 days, he was pretty much back to normal and was released to go home. He has been fine ever since, though he did have a mild cold at one point.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Pt self reported anaphylactic reaction.  Unknown time course and severity.  Pt did not seek any known treatment.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: pt was supposed to have received bexsero and revceived trumenba
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Fatigue and nausea.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Cough.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Nurse gave dose from the Moderna 6 year to 11 year old COVID vaccine vial instead of the correct vial for Moderna 6 months -5 years old. Dose given was correct at 0.25 mL. Parent does not answer the phone and has a voicemail box which is full and cannot accept any messages.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Gastrointestinal tube insertion, Renal tubular necrosis
Clinical narrative: Patient admitted 01/13/22 and tested + for covid.  Expired 02/03/2022 .  Had complicated course, developed acute tubular necrosis, required feeding tube.  Developed covid pneumonia.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient admitted 01/13/22 and tested + for covid.  Expired 02/03/2022 .  Had complicated course, developed acute tubular necrosis, required feeding tube.  Developed covid pneumonia.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Fever.  Headache, sore arm   Fatigue
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeding disorder, Hypophagia, Menstruation irregular, Mobility decreased
Clinical narrative: Severe arm pain first dose, not able to sleep for 24 hours even with OTC meds Severe arm pain second dose, but able to sleep 3 hrs with OTC meds first night  Arm pain disrupted seep and could not use arm for one week the first time and three days after the second dose  Couldn't eat or drink for 48hrs following each dose. Didn't eat more than one small meal for a day for three months, trouble keeping food down  Periods did not return to normal schedule or bleeding regularly until August 2022  Severe fatigue until May of 2022, unable to stay awake more than three hours a day starting, gradually working up to 12 hours a day awake in May.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sleep disorder, Somnolence
Clinical narrative: Severe arm pain first dose, not able to sleep for 24 hours even with OTC meds Severe arm pain second dose, but able to sleep 3 hrs with OTC meds first night  Arm pain disrupted seep and could not use arm for one week the first time and three days after the second dose  Couldn't eat or drink for 48hrs following each dose. Didn't eat more than one small meal for a day for three months, trouble keeping food down  Periods did not return to normal schedule or bleeding regularly until August 2022  Severe fatigue until May of 2022, unable to stay awake more than three hours a day starting, gradually working up to 12 hours a day awake in May.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal cavity drainage, Abdominal distension, Abdominal pain upper, Acute respiratory failure, Ascites
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Cardiogenic shock, Chemotherapy, Colostomy, Computerised tomogram thorax abnormal
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Culture positive, Drain placement, Echocardiogram abnormal, Fungal test positive
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Gram stain positive, Haemoperitoneum, Hypoxia, Intensive care, Intestinal perforation
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Malnutrition, Pericardial effusion, Peritonitis bacterial, Pleural effusion, Proctectomy
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Shock, Sudden death
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD  Admission Date: 8/5/2022  PRESENTING PROBLEM: Pleural effusion [J90] Other ascites [R18.8] Pleural effusion, right [J90] Acute respiratory failure with hypoxia (HCC) [J96.01] Hypoxia [R09.02] Shock (HCC) [R57.9]   HOSPITAL COURSE: The patient is a 43 y.o. female with a PMH of anxiety, anemia, and rectal cancer. Patient presented to the ED for generalized upper abdominal pain and fulliness. She has metastasis of her rectal cancer and has had multiple rounds of chemothreapy and abdominal perineal resection with end colostomy. She ended up with bacterial peritonitis, septic and cardiogenic shock requiring pressors in the ICU. CT revealed large right pleural effusion, a mild amount of ascites, and no evidence of mechanical bowel obstruction. IR drained 2.2L of yellow-colored ascites drained form her abdomen which has grown GNR, GPR, GPC, and yeast for which infectious disease was concerned was 2/2 to a bowel perforation. She was started on broad spectrum antibiotics. On echo, it showed a pericardial effusion and cardiology was consulted and recommended diuresis and re-evaluation on ech in 48 hours pending further clinical stabilization. She was incidentally covid 19 positive without symptoms and severe chronic protein calorie malnutrition. It was later discovered that she had an active intraperitoneal hemorrhage and peritoneal drain was placed. Prognosis was poor. Hospice care was consulted and eventually, transitioned out of the ICU to IM service where she would await a hospice facility that could take her with covid 19 infection. While awaiting isolation, the patient declined further and passed on 8/22/2022 suddenly. She was discharged deceased and the family was offered condolences.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Laboratory test, Skin lesion, Viral infection
Clinical narrative: Unspecific viral infection characterized by skin and mucous membrane lesions Prescribed:  1-prednisone 50 mg.   2- triamcinolone acetonide 0.1 3-doxycycline hyclate 100 mg capsule
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash macular
Clinical narrative: Patient developed rash to bilateral arms approximately 15 minutes after dose administered.  right arm rash worse than left.  Rash was from elbows down on forearms only.  Administered 50 mg Benadryl liquid and after 15 minutes rash to L arm  had disappeared and rash to R arm had lessened.  Patient did not complain of itching or difficulty breathing.  Rash was flat and blotchy red.  Rash was almost completely gone after 20 minutes.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Intensive care, Oxygen saturation decreased
Clinical narrative: Hospitalization: Admitted 8/15/2022; discharged 8/19/2022. Presentation to the ED: Shortness of breath; decreased oxygen saturation while on room air. Treatment: Patient admitted and treated with corticosteroids and oxygen therapy. Discharge: Home.
Age: 42.0
Sex: F
Vaccine: COVID19, PNC13
Symptoms: Abdominal pain, COVID-19, Computerised tomogram abdomen abnormal, Computerised tomogram thorax normal, Diabetes mellitus
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 8/17/2022 Discharge Date: 8/23/22      HOSPITAL COURSE: The patient is a 43 y.o. female who was admitted for acute pancreatitis and sepsis secondary to Covid 19 infection.    Patient developed fevers and shortness of breath on 8/9/22 and tested positive for COVID on 8/11.  On 8/13 pt developed vomiting and generalized abdominal pain. Symptoms continued to worsen and she presented to ED on 8/17 where she was noted to have tachycardia and leukocytosis. Lipase was >3000 and CT a/p showed inflammation and edema of the pancreas. She was initially treated with IV pain medicine and kept NPO. CT with steroid prep was obtained (pt had allergy to contrast) and ruled out PE. Her pain gradually improved and she was transitioned to oral pain medications. She did have some diarrhea during admission which could have been due to Covid or pancreatitis. Pt was also newly diagnosed with diabetes this admission, A1c 7.1. She was not started on metformin due to acute pancreatitis. Prior to discharge she was tolerating soft diet and pain was well controlled on oral medications. She was medically and vitally stable for discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, PNC13
Symptoms: Diarrhoea, Dyspnoea, Glycosylated haemoglobin increased, Leukocytosis, Lipase increased
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 8/17/2022 Discharge Date: 8/23/22      HOSPITAL COURSE: The patient is a 43 y.o. female who was admitted for acute pancreatitis and sepsis secondary to Covid 19 infection.    Patient developed fevers and shortness of breath on 8/9/22 and tested positive for COVID on 8/11.  On 8/13 pt developed vomiting and generalized abdominal pain. Symptoms continued to worsen and she presented to ED on 8/17 where she was noted to have tachycardia and leukocytosis. Lipase was >3000 and CT a/p showed inflammation and edema of the pancreas. She was initially treated with IV pain medicine and kept NPO. CT with steroid prep was obtained (pt had allergy to contrast) and ruled out PE. Her pain gradually improved and she was transitioned to oral pain medications. She did have some diarrhea during admission which could have been due to Covid or pancreatitis. Pt was also newly diagnosed with diabetes this admission, A1c 7.1. She was not started on metformin due to acute pancreatitis. Prior to discharge she was tolerating soft diet and pain was well controlled on oral medications. She was medically and vitally stable for discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, PNC13
Symptoms: Oedema, Pancreatitis acute, Pyrexia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 8/17/2022 Discharge Date: 8/23/22      HOSPITAL COURSE: The patient is a 43 y.o. female who was admitted for acute pancreatitis and sepsis secondary to Covid 19 infection.    Patient developed fevers and shortness of breath on 8/9/22 and tested positive for COVID on 8/11.  On 8/13 pt developed vomiting and generalized abdominal pain. Symptoms continued to worsen and she presented to ED on 8/17 where she was noted to have tachycardia and leukocytosis. Lipase was >3000 and CT a/p showed inflammation and edema of the pancreas. She was initially treated with IV pain medicine and kept NPO. CT with steroid prep was obtained (pt had allergy to contrast) and ruled out PE. Her pain gradually improved and she was transitioned to oral pain medications. She did have some diarrhea during admission which could have been due to Covid or pancreatitis. Pt was also newly diagnosed with diabetes this admission, A1c 7.1. She was not started on metformin due to acute pancreatitis. Prior to discharge she was tolerating soft diet and pain was well controlled on oral medications. She was medically and vitally stable for discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, PNC13
Symptoms: Tachycardia, Vomiting
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 8/17/2022 Discharge Date: 8/23/22      HOSPITAL COURSE: The patient is a 43 y.o. female who was admitted for acute pancreatitis and sepsis secondary to Covid 19 infection.    Patient developed fevers and shortness of breath on 8/9/22 and tested positive for COVID on 8/11.  On 8/13 pt developed vomiting and generalized abdominal pain. Symptoms continued to worsen and she presented to ED on 8/17 where she was noted to have tachycardia and leukocytosis. Lipase was >3000 and CT a/p showed inflammation and edema of the pancreas. She was initially treated with IV pain medicine and kept NPO. CT with steroid prep was obtained (pt had allergy to contrast) and ruled out PE. Her pain gradually improved and she was transitioned to oral pain medications. She did have some diarrhea during admission which could have been due to Covid or pancreatitis. Pt was also newly diagnosed with diabetes this admission, A1c 7.1. She was not started on metformin due to acute pancreatitis. Prior to discharge she was tolerating soft diet and pain was well controlled on oral medications. She was medically and vitally stable for discharge.
Age: 45.0
Sex: M
Vaccine: SMALLMNK, SMALLMNK
Symptoms: Injection site haematoma, Injection site pruritus, Injection site swelling, Injection site vesicles, Ultrasound scan
Clinical narrative: 6 days after 1st dose, pt developed a hematoma at site of subcutaneous injection.  Saw PCP and had ultrasound done diagnosing it as a hematoma.  Resolved before 2nd dose.  No treatment given.  1 day after 2nd dose, pt developed blisters at site of intradermal injection, red (>10 cm), swelling and itching.  Saw PCP.  Treating with calamine lotion.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dizziness, Syncope
Clinical narrative: Pt had a syncopal event with associated dizziness. Vitals: 125/77, 50, 17.  Pt given juice and crackers. Pt stable and released from the vaccination site
Age: 41.0
Sex: M
Vaccine: UNK
Symptoms: Erythema, Injection site erythema, Injection site warmth
Clinical narrative: Pt arrived to health center Wed 8/24/22, reporting he had dose #2 MonkeyPox vaccine on Mon 8/22/22; Tues 8/23 reports redness, had photo: small lemon size area of pink/red around posterior rt bicep. 8/24 on inspection, noted large, very red area , from lower deltoid to just above elbow, hot to touch. Pt temp 97.8F, no axillary or cervical lymphadenopathy noted; Sent to urgent care. Pt reported back to this RN he was placed on 7 day course of Cephaxalin PO .
Age: 26.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: First attempt of jynneos vaccine given in left arm with no elevation of the skin or wheal present after administering.  Second dose attempt of jynneos in left arm with a wheal formed.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache
Clinical narrative: Headache, fatigue, joint ache Rest, acetaminophen, fluids Slowly recovering
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Pt died in hospital on 8/22/22
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Arthropathy, Condition aggravated, Gait disturbance, Impaired self-care, Loss of personal independence in daily activities
Clinical narrative: He got his vaccine, exactly 2 months later he was lying in bed, opened his eyes and felt like he was in a cement mixer.  The whole room was moving from left to right.  He closed his eyes and the feeling went away, but as soon as he opened his eyes again the room was spinning again.  He had to stay in bed for a while, he was alone and had no family to take care of him.  He then had some healthcare workers come and he was not able to take care of himself and do his chores.  The spinning stopped after about a year, and took him a while to adapt to it.  He had to use a wheelchair to get around, he can walk some but cannot walk for long.  His knee issue he had as a child then started up again due to his loss of not using his leg.  He can get down 6 steps to get to his truck, but has to be very careful.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Vertigo, Wheelchair user
Clinical narrative: He got his vaccine, exactly 2 months later he was lying in bed, opened his eyes and felt like he was in a cement mixer.  The whole room was moving from left to right.  He closed his eyes and the feeling went away, but as soon as he opened his eyes again the room was spinning again.  He had to stay in bed for a while, he was alone and had no family to take care of him.  He then had some healthcare workers come and he was not able to take care of himself and do his chores.  The spinning stopped after about a year, and took him a while to adapt to it.  He had to use a wheelchair to get around, he can walk some but cannot walk for long.  His knee issue he had as a child then started up again due to his loss of not using his leg.  He can get down 6 steps to get to his truck, but has to be very careful.
Age: 32.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: The patient presented to the clinic on 08/22/2022 c/o of pain 10/10, swelling, and hot to touch at the injection site. The patient was vaccinated on 8/19/2022 and stated symptoms started on 8/20/2022, pt took over-the-counter medication for swelling and pain. The patient had  Cephalexin 500 mg prescribed on 8/22/2022. The patient then returned to the clinic on 8/24/22 complaining of persistent pain at the injection site and swelling, the patient stated she is still taking antibiotics and ibuprofen. The patient was advised to go to the emergency department for persisting symptoms.
Age: 31.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Syncope
Clinical narrative: Pt had a syncopal event Vitals: 98/88, 72, 100% Pt given juice. Pt stable and released from the vaccination site @17:00.
Age: 41.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect dose administered, Needle issue
Clinical narrative: When administering the Monkeypox Jynneos vaccine intradermally, RN had needle in pt.'s L forearm too superficially and most of vaccine leaked out.  Another RN then placed Monkeypox Jynneos vaccine 0.1ml intradermally to L forearm at least 2 inches away from original site.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: WHEN SCREENING PATIENT WE ASKED IF PATIENT HAD ANY OTHER VACCINATIONS FOR COVID AND THE PATIENT ANSWERED NO AFTER ADMINISTERING THE VACCINE AND UPON BILLING THE VACCINE WE SEARCHED THE LOCAL DATABASE AND THE PATIENT HAS HAD PREVIOUS COVID VACCINATIONS (PFIZER X2, MODERNA X 4, JANSSEN X1) WE CALLED THE PATIENT TO GET AN EXPLANATION AND EXPLAIN THAT WE WILL NOT ADMINISTER A 2ND NOVAVAX DOSE
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Capillaritis, Rash papular, Skin lesion
Clinical narrative: Vaccine received on 22 April 2022 approximately 3 weeks later lesion noticed on lower right leg. Appointment made with PCM clinic and seen on 1 June 2022. Referral made to dermatology at time of PCM visit. Seen by dermatology 10 Aug 2022 with diagnosis of lichen aureus/capillaritis to torso and lower extremities. Dermatology prescribed eucrisa ointment, currently awaiting authorization for dispensing.  Lesions on-going. Per dermatologist, to return to clinic for biopsy (scraping) if no improvement with prescribed treatment.
Age: 37.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Lip swelling, Pruritus, Swelling face, Urticaria
Clinical narrative: Overall body itching with diffuse hives and swelling of lips and face with itching developed approximately 1 hour after vaccines were administered. Patient took 1 benedryl and called Employee Health to report adverse reaction. Patient completed an event report and was escorted to Emergency Department for follow up. Patient had epi-pen in her possession.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: Pain radiating down arm that evening. Arm pain continuing, unable to lift arm.